The US Navy Medicine has granted a Indefinite Delivery Indefinite Quantity (IDIQ) contract of $497m to Lovelace Respiratory Research Institute (LRRI).

The contract covers medical problems that Marines, soldiers, sailors and airmen face in war zones, such as biomedical and psychological issues, and clinical research.

The award represents a three year base contract with an additional option of two years.

The LRRI is dedicated to improve public health through research on the prevention, treatment and cure of respiratory disease.

LRRI cures respiratory diseases through research aimed at understanding their causes and biological mechanisms; assessing and eliminating exposures to respiratory health hazards; and developing improved therapeutics, vaccines, and diagnostics.